NIH begins clinical trial of hydroxychloroquine and azithromycin to treat coronavirus patients

NIH doses first coronavirus patient in trial of hydroxychloroquine and antibiotic combo touted by Trump in hopes the controversial drug will cut risks of hospitalization and death The NIH has begun a clinical trial testing anti-malaria drug hydroxychloroquine and antibiotic azithromycin in coronavirus patients Patients will either be assigned the experimental treatment or a pair … Read more

Study finds just 1% of coronavirus patients who received plasma suffered side effects

An experimental treatment using blood plasma is safe to use on coronavirus patients, a new study suggests. Less than one percent of about 5,000 patients from around the US who received  plasma from people who had recovered from the virus suffered ‘serious adverse effects.’ Additionally, one week later, only about 15 percent died, which the … Read more

80% of children in Italian hospital with rare inflammatory disorder tested positive for coronavirus

A new analysis suggests the rare inflammatory condition increasingly being seen in young children is in fact linked to the novel coronavirus. Researchers in Lombardy, Italy – the epicenter of the country’s outbreak – looked at 10 pediatric cases with symptoms such as a full body rash and swollen hands and feet. By comparison, over … Read more

Coronavirus: US to get French vaccine first after funding company

Americans will get priority for French drugmaker Sanofi’s coronavirus vaccine because the US rushed to be first to give the company funding for its research back in February, chief executive officer Paul Hudson told Bloomberg.  ‘The US government has the right to the largest pre-order because it’s invested in taking the risk’ by giving Sanofi … Read more